Display Page As Plain Text NASA Bioastronautics Roadmap SLSD JSC
Home | Missions | CC Areas | Disciplines | Risks | R & T Questions | Tasks | Deliverables | Processes | Search | Links | Help
Skip Risk List

Risks

   
 
  Current Selection Filters
 
 
 
 
All
 
 
Skip Risk/EQ/Task List
45 Risks found.
1 Accelerated Bone Loss and Fracture Risk
2 Impaired Fracture Healing
3 Injury to Joints and Intervertebral Structures
4 Renal Stone Formation
5 Occurrence of Serious Cardiac Dysrhythmias
6 Diminished Cardiac and Vascular Function
7 Define Acceptable Limits for Contaminants in Air and Water
8 Immune Dysfunction, Allergies and Autoimmunity
9 Interaction of Space flight Factors, Infections and Malignancy
10 Alterations in Microbes and Host Interactions
12345Next
   
Risk 6: Diminished Cardiac and Vascular Function  

 
 
Crosscutting Area : Human Health and Countermeasures
 
jump to contentDiscipline : Cardiovascular Alterations
 
Description : Diminished cardiac function, orthostatic or postural hypotension, and the impaired ability to perform strenuous tasks on a planetary surface may occur due to prolonged exposure to hypogravity.
 
Context / Risk Factors : This risk may be influenced by altered neural and hormonal regulation, flight duration, or gender.
 
Justification / Rationale : Some, but not all, studies suggest that prolonged exposure to microgravity may lead to reduction of cardiac mass and reduced cardiac function. Carefully controlled inflight studies are required to document this finding and determine the clinical signficance.
 
Reference Missions :
 
Skip Mission Links
ISS Lunar Mars
 
 
  Risk Rating
Priority 2
 
  Current Countermeasures
  • In flight exercise
 
  Projected Countermeasures or Mitigations and Other Deliverables with their CRL/TRL scores
  • Artificial G exposure
  • Drugs that affect cardiac mass and function
  • Improved exercise and conditioning program
 
  Research & Technology Questions Skip EQ List
No.
Sorted in Ascending Order
Question Priority
6a Does long-duration space flight lead to diminished cardiac function? If so, what mechanisms are involved? 1
6b Is space flight induced diminished cardiac function reversible? 1
6c What is the extent of reduction in cardiac function and/or mass associated with long-duration space flight? 1
6d Can susceptibility to reduced cardiac function be predicted for individual crewmembers? 2
6e What countermeasures may be effective in mitigating the occurrence of reduced cardiac function or mass? 1
6f What are the physiological and environmental factors by which space flight decreases orthostatic tolerance? 1
6g How does duration of space flight affect the severity and time course of orthostatic intolerance, and what are the mechanisms? 2
6h Is orthostatic intolerance likely to develop on the surface of Mars or the moon? 1
6i Can space flight induced orthostatic intolerance be predicted for individual crewmembers? 1
6j What countermeasures can be developed to overcome or prevent orthostatic intolerance? 1
6k What are the physiological and environmental factors by which space flight decreases aerobic exercise capacity? 1
6l Is the observed decrease in exercise capacity directly related to duration of space flight? 1
6m Can the degree of reduced aerobic exercise capacity be predicted for individual crewmembers? 1
6n What countermeasures can be developed to overcome microgravity-induced reduction in aerobic exercise capacity? 1
 
  Related Risks
Bone Loss
Accelerated Bone Loss and Fracture Risk
Injury to Joints and Intervertebral Structures
Cardiovascular Alterations
Occurrence of Serious Cardiac Dysrhythmias
Environmental Health
Define Acceptable Limits for Contaminants in Air and Water
Skeletal Muscle Alterations
Reduced Muscle Mass, Strength, and Endurance
Increased Susceptibility to Muscle Damage
Clinical Capabilities
Monitoring and Prevention
Major Illness and Trauma
Pharmacology of Space Medicine Delivery
Ambulatory Care
Rehabilitation on Mars
 
  Important References
Blomqvist LD, Lane CG, Wright SJ, Meny GM, Levine BD, Buckey JC, Peshock RM, Weatherall P, Stray-Gundersen J, Gaffney FA, Watenpaugh DE, Arbeille P, and Baisch F. Cardiovascular regulation in microgravity. In: Scientific Results of the German Spacelab Mission D-2: Proceedings of the Norderney Symposium, edited by Sahm PR, Keller MH, and Schiewe B.. Koln, Germany: Wissenschaftliche Projektfuhrung D-2 (c/o Deutsches Zentrum fur Luft- und Raumfahrt), 1994, p. 688-690.
Charles JB, Frey MA, Fritsch-Yelle JM, Fortner GW. Cardiovascular and Cardiorespiratory Function. In Huntoon C, Antipov V, Grigoriev A (editors), Volume III, Book I (humans in Space) Space Biology and Medicine, AIAA, Reston, VA, 1996.
The Neurolab Spacelab Mission: Neuroscience Research in Space: Results from the STS-90 Neurolab Spacelab Mission: Section 4 Blood Pressure Control. pp. 171-205. Buckey J and Homick J (editors). NASA SP-2003-535, 2003.
 
NASA
Page Last Updated:  February 12, 2008
Page Editor:  Stuart S. Engelhardt Content Manager:  John B. Charles NASA Official:  John B. Charles Budgets, Strategic Plans, and Accountability Reports Equal Employment Opportunity Data Posted Pursuant to the No Fear Act Information-Dissemination Policies and Inventories Freedom of Information Act President's Management Agenda Privacy Policy & Important Notices Inspector General Hotline Contact SLSD Space Life Sciences Directorate Johnson Space Center USA.gov ExpectMore.gov